Rizvi Syed Ali-aamir bought RCKT

October 6, 2025 · Form 4 insider transaction

Rizvi Syed Ali-aamir bought 62,893 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
62,893
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 6, 2025
Filing dateOctober 8, 2025
Shares owned after345,911
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents RSUs that will vest in two installments. One-half (1/2) of the RSUs will become fully vested on October 6, 2026 and the remaining RSUs will vest on the second anniversary of the grant date, such that all of the shares underlying the award will be vested on the date two (2) years after the grant date, subject to the reporting person's continued employment with the Issuer or any of its subsidiaries.

View the original Form 4 on SEC EDGAR